comparemela.com

Latest Breaking News On - Meritxell bellet ezquerra - Page 1 : comparemela.com

Year in Review: Breast Cancer

Practice-changing therapy for HER2-low breast cancer, potential for some women to skip surgery

United statesFrance generalIsrael generalDana farber cancer instituteUniversity of pennsylvaniaComunidad autonoma de catalunaAngela demicheleHeathera parsonsJane lowe meiselAnnelie johanssonHenry kuererNancy davidsonMeritxell bellet ezquerraKarolinska instituteAmerican society of clinical oncologyMd anderson cancer center

Breast Cancer Updates From ESMO 2022

Results from the TROPiCS-02, DATA, GIM2, and METEORA-II trials may help inform the treatment of breast cancer.

United statesIsrael generalComunidad autonoma de catalunaSan franciscoBellet ezquerraPeter dubskyMeritxell bellet ezquerraUniversity of californiaBreast centre klinik stHebron institute of oncologySacituzumab govitecan improvesHebron instituteDose dense chemo improvesLucia del mastroPoliclinico san martinoBreast centre klinik

Antibody-Drug Conjugate Prolongs Survival in Metastatic Breast Cancer

Positive outcome with sacituzumab govitecan leads to questions about ADC sequencing

United statesIsrael generalFrance generalComunidad autonoma de catalunaCharles bankheadMeritxell bellet ezquerraAmerican society of clinical oncologyHebron institute of oncologyUniversity of california san franciscoEuropean society for medical oncologyCalifornia san franciscoEuropean societyMedical oncologyHebron instituteAmerican societyClinical oncology

vimarsana © 2020. All Rights Reserved.